Whole Body MRI Screening for Li-Fraumeni Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This study is evaluating Whole Body MRI as a possible screening tool to diagnose cancer for people with LFS and other inherited cancer predisposition syndromes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
Is whole-body MRI screening safe for humans?
Whole-body MRI screening is generally considered safe for humans, as it does not use ionizing radiation, which is a concern for people with Li-Fraumeni syndrome who are sensitive to radiation. However, there is a high rate of false-positive results, which can lead to unnecessary stress and additional testing.12345
How does whole-body MRI screening differ from other treatments for Li-Fraumeni Syndrome?
Whole-body MRI screening is unique for Li-Fraumeni Syndrome because it uses magnetic resonance imaging to regularly check the entire body for tumors without exposing patients to radiation, which they are particularly sensitive to. This approach helps in early detection of various cancers associated with the syndrome, unlike other methods that might not cover the whole body or could involve radiation.12346
What data supports the effectiveness of the treatment Whole Body MRI for Li-Fraumeni Syndrome?
Whole Body MRI (WB-MRI) is effective in identifying asymptomatic tumors in individuals with Li-Fraumeni Syndrome, as shown in studies where it detected malignant tumors in some patients who showed no symptoms. This screening method is particularly useful for people with this syndrome because they are at high risk for multiple types of cancer.12346
Who Is on the Research Team?
Allison O'Neill, MD
Principal Investigator
Dana-Farber Cancer Institute
Are You a Good Fit for This Trial?
This trial is for adults and children with Li-Fraumeni Syndrome or other inherited cancer predisposition syndromes. Participants must be in stable remission from any previous cancers, not pregnant, and able to give informed consent. It excludes those currently with active cancer (except certain types), pregnant/nursing women, and anyone with metal implants that affect MRI safety.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Whole Body MRI Scanning
Participants undergo Whole Body MRI scans to detect early-stage cancers
Follow-up
Participants are monitored for detection of prevalent and incident cancers
What Are the Treatments Tested in This Trial?
Interventions
- Whole Body MRI
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor